Vicarious Surgical Inc.

NYSE:RBOT Voorraadrapport

Marktkapitalisatie: US$47.7m

Vicarious Surgical Toekomstige groei

Future criteriumcontroles 0/6

Vicarious Surgical's earnings are forecast to decline at 3.8% per annum while its annual revenue is expected to grow at 66.3% per year. EPS is expected to grow by 32.8% per annum. Return on equity is forecast to be -143.4% in 3 years.

Belangrijke informatie

-3.8%

Groei van de winst

32.8%

Groei van de winst per aandeel

Medical Equipment winstgroei17.4%
Inkomstengroei66.3%
Toekomstig rendement op eigen vermogen-143.4%
Dekking van analisten

Low

Laatst bijgewerkt13 Aug 2024

Recente toekomstige groei-updates

Recent updates

Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely

Aug 16
Here's Why Vicarious Surgical (NYSE:RBOT) Must Use Its Cash Wisely

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Mar 05
Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Nov 24
Is Vicarious Surgical (NYSE:RBOT) In A Good Position To Invest In Growth?

Vicarious Surgical: Huge Potential But Low Margin Of Safety To Commercialization

Aug 24

Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation

Jul 18
Here's Why We're Watching Vicarious Surgical's (NYSE:RBOT) Cash Burn Situation

Vicarious Surgical: Cash Burn Adds To Downside Risk

May 26

Vicarious Surgical Non-GAAP EPS of -$0.16 beats by $0.02

Feb 13

Vicarious Surgical Non-GAAP EPS of -$0.18 misses by $0.03

Nov 07

Vicarious Surgical Non-GAAP EPS of -$0.16 misses by $0.02

Aug 08

Vectoring In On Vicarious Surgical Inc.

Jun 23

Vicarious Surgical: Developing Minimally Invasive VR Surgical System

Nov 29

Winst- en omzetgroeiprognoses

NYSE:RBOT - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2026N/A-77N/AN/A3
12/31/2025N/A-74N/AN/A3
12/31/2024N/A-64N/AN/A3
6/30/2024N/A-61-55-54N/A
3/31/2024N/A-61-60-58N/A
12/31/2023N/A-71-64-62N/A
9/30/2023N/A-69-71-69N/A
6/30/2023N/A-78-68-66N/A
3/31/2023N/A-64-69-65N/A
12/31/2022N/A5-67-61N/A
9/30/2022N/A38-58-53N/A
6/30/2022N/A18-57-52N/A
3/31/2022N/A13-47-44N/A
12/31/2021N/A-35-35-33N/A
9/30/2021N/A-61-28-27N/A
6/30/2021N/A-19-17-16N/A
3/31/2021N/A-15-14-14N/A
12/31/2020N/A-13-12-12N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: RBOT is forecast to remain unprofitable over the next 3 years.

Winst versus markt: RBOT is forecast to remain unprofitable over the next 3 years.

Hoge groeiwinsten: RBOT is forecast to remain unprofitable over the next 3 years.

Omzet versus markt: RBOT is forecast to have no revenue next year.

Hoge groei-inkomsten: RBOT is forecast to have no revenue next year.

Groeiprognoses winst per aandeel

Toekomstig rendement op eigen vermogen

Toekomstige ROE: RBOT is forecast to be unprofitable in 3 years.

Ontdek groeibedrijven

7D

1Y

7D

1Y

7D

1Y